Back
OptimizeRx Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
50
OPRX
OptimizeRx
Last Price:
$11.42
Seasonality Move:
4.73%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
OptimizeRx Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.22 | Buy |
20-day SMA: | 9.48 | Buy |
50-day SMA: | 8.51 | Buy |
200-day SMA: | 6.86 | Buy |
8-day EMA: | 10.37 | Buy |
20-day EMA: | 9.66 | Buy |
50-day EMA: | 8.59 | Buy |
200-day EMA: | 7.79 | Buy |
OptimizeRx Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.68 | Buy |
Relative Strength Index (14 RSI): | 66.72 | Buy |
Chaikin Money Flow: | 287456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.32 - 10.16) | Buy |
Bollinger Bands (100): | (5.1 - 8.84) | Buy |
OptimizeRx Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OptimizeRx Stock
Is OptimizeRx Stock a Buy?
-
OptimizeRx share price is 11.43 while OPRX 8-day simple moving average is 10.22, which is a Buy signal.
-
The stock price of OPRX is 11.43 while OptimizeRx 20-day SMA is 9.48, which makes it a Buy.
-
OptimizeRx 50-day simple moving average is 8.51 while OPRX share price is 11.43, making it a Buy technically.
-
OPRX stock price is 11.43 and OptimizeRx 200-day simple moving average is 6.86, creating a Buy signal.
OPRX Technical Analysis vs Fundamental Analysis
Sell
50
OptimizeRx (OPRX)
is a Sell
Is OptimizeRx a Buy or a Sell?
-
OptimizeRx stock is rated a SellThe current OptimizeRx [OPRX] share price is $11.43. The Score for OPRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
OptimizeRx Stock Info
Market Cap:
211.4M
Price in USD:
11.43
Share Volume:
310.9K
OptimizeRx 52-Week Range
52-Week High:
13.33
52-Week Low:
3.78
Sell
50
OptimizeRx (OPRX)
is a Sell
OptimizeRx Share Price Forecast
-
What is the OptimizeRx stock price today?The OptimizeRx stock price is 11.43 USD today.
-
Will OPRX stock go up or go down?OptimizeRx> share price is forecast to RISE/FALL based on technical indicators
-
Is OptimizeRx overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, OptimizeRx is overvalued.
Is OptimizeRx Stock a Buy?
-
OptimizeRx share price is 11.43 while OPRX 8-day exponential moving average is 10.37, which is a Buy signal.
-
The stock price of OPRX is 11.43 while OptimizeRx 20-day EMA is 9.66, which makes it a Buy.
-
OptimizeRx 50-day exponential moving average is 8.59 while OPRX share price is 11.43, making it a Buy technically.
-
OPRX stock price is 11.43 and OptimizeRx 200-day simple moving average is 7.79, creating a Buy signal.
Fundamental Analysis of OptimizeRx
Is OptimizeRx a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.11 per share.
Technical Analysis of OptimizeRx
Should I short OptimizeRx stock?
-
OPRX Moving Average Covergence Divergence (MACD) indicator is 0.68, suggesting OptimizeRx is a Buy
-
OptimizeRx Relative Strength Index (RSI) is 66.72, which suggest OptimizeRx is overbought
-
The Bollinger Bands (25) for OptimizeRx is (8.32 - 10.16), which suggest OptimizeRx is a Buy
-
The Bollinger Bands (100) for OptimizeRx is (5.1 - 8.84), which suggest OptimizeRx is a Buy
* OptimizeRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.